Using non-radioactive assay as a screening tool for membrane protein modulators is well-documented in scientific literature and has been widely used for studying the potassium channel family. The same principle of the nonradioactive Rb+ assay can be easily applied to more membrane protein targets than currently validated. The following publications represent a partial collection of ICR applications useful to both pharmaceutical labs and academic institutions. Please contact Aurora for further information regarding your specific protocol requirements.